Home

High Court decision on cancer drug

2008-09-11T13:21:00

The High Court has overturned a primary care trust's refusal to fund cancer drug Revlimid for a cancer suffer with only months to live.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here